MiRNA signatures in sera of patients with active pulmonary tuberculosis

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Miotto, Paolo ^a   Mwangoka, Grace ^b   Valente, Ilaria C ^a   Norbis, Luca ^a   Sotgiu, Giovanni ^c   Bosu, Roberta ^c   Ambrosi, Alessandro ^d   Codecasa, Luigi R ^e   Goletti, Delia ^f   Matteelli, Alberto ^g   Ntinginya, Elias N ^h   Aloi, Francesco ^i,j   Heinrich, Norbert ^k   Reither, Klaus ^b,l   Cirillo, Daniela M ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b IFAKARA HEALTH INSTITUTE   (Tanzania)

^c UNIVERSITY OF SASSARI   (Italy)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^e OSPEDALE NIGUARDA CA GRANDA   (Italy)

^f NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^g UNIVERSITY OF BRESCIA   (Italy)

^h NATIONAL INSTITUTE OF MEDICAL RESEARCH   (Tanzania)

ⁱ Nsambya Home Care   (Uganda)

^j Italian Association for Solidarity among People (AISPO NGO)   (Uganda)

^k UNIVERSITY OF MUNICH   (Germany)

^l UNIVERSITY OF BASEL   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MICRORNAS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPPORT VECTOR MACHINES; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84894258313     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080149     Document Type: Article

References (49)

1. World Health Organization (2012) Global tuberculosis report. Geneva, ISBN 978 92 4 156450 2.
2. Zumla A, Atun R, Maeurer M, Mwaba P, Ma Z, et al. (2011) Viewpoint: Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection. Trop Med Int Health 16(1): 79-83. doi: 10.1111/j.1365-3156.2010. 02665.x.
3. McNerney R, Maeurer M, Abubakar I, Marais B, McHugh TD, et al. (2011) Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. J Infect Dis 205: S147-158. doi: 10.1093/infdis/jir860.
4. Amanatidou V, Syridou G, Mavrikou M, Tsolia MN (2012) Latent tuberculosis infection in children: diagnostic approaches. Eur J Clin Microbiol Infect Dis 31(7): 1285-1294. doi: 10.1007/s10096-011-1524-3.
5. Schaaf HS, Collins A, Bekker A, Davies PD (2010) Tuberculosis at extremes of age. Respirology 15(5): 747-763. doi: 10.1111/j.1440-1843.2010.01784.x.
6. Perez-Velez CM, Marais BJ (2012) Tuberculosis in children. N Engl J Med 367(4): 348-361. doi: 10.1056/NEJMra1008049.
7. Pearce EC, Woodward JF, Nyandiko WM, Vreeman RC, Ayaya SO (2012) A systematic review of clinical diagnostic systems used in the diagnosis of tuberculosis in children. AIDS Res Treat 2012: 401896. doi: 10.1155/2012/401896.
8. Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, et al. (2009) LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 33(5): 956-973. doi: 10.1183/09031936.00120908.
9. Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A (2011) Immunological biomarkers of tuberculosis. Nat Rev Immunol 11(5): 343-354. doi: 10.1038/nri2960.
10. Norbis L, Miotto P, Alagna R, Cirillo DM (2013) Tuberculosis: lights and shadows in the current diagnostic landscape. New Microbiol 36(2): 111-120.
11. Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, et al. (2010) Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 375(9729): 1920-1937. doi: 10.1016/S0140-6736(10)60359-5.
12. Lawn SD, Zumla AI (2011) Tuberculosis. Lancet 378(9785): 57-72. doi:10.1016/S0140-6736(10)62173-3.
13. Wallis RS, Kim P, Cole S, Hanna D, Andrade BB, et al. (2013) Tuberculosis biomarkers discovery: developments, needs, and challenges. Lancet Infect Dis 13(4): 362-372. doi: 10.1016/S1473-3099(13)70034-3.
14. Kim VN, Nam JW (2006) Genomics of microRNA. Trends Genet 22(3): 165-173.
15. Flynt AS, Lai EC (2008) Biological principles of microRNA-mediated regulation: shared themes amid diversity. Nat Rev Genet 9(11): 831-842. doi: 10.1038/nrg2455.
16. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT (2011) MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13(4): 423-433. doi: 10.1038/ncb2210.
17. Chen X, Liang H, Zhang J, Zen K, Zhang CY (2012) Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol 22(3): 125-132. doi:10.1016/j.tcb.2011.12.001.
18. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, et al. (2010) The MicroRNA spectrum in 12 body fluids. Clin Chem 56(11): 1733-1741. doi:10.1373/clinchem.2010.147405.
19. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, et al. (2011) MicroRNAs in body fluids - the mix of hormones and biomarkers. Nat Rev Clin Oncol 8(8): 467-477. doi: 10.1038/nrclinonc.2011.76.
20. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, et al. (2008) Serum microRNAs are promising novel biomarkers. PLoS One 3(9): e3148. doi:10.1371/journal.pone.0003148.
21. Fu Y, Yi Z, Wu X, Li J, Xu F (2011) Circulating microRNAs in patients with active pulmonary tuberculosis. J Clin Microbiol 49(12): 4246-4251. doi:10.1128/JCM.05459-11.
22. Qi Y, Cui L, Ge Y, Shi Z, Zhao K, et al. (2012) Altered serum microRNAs as biomarkers for the early diagnosis of pulmonary tuberculosis infection. BMC Infect Dis 12: 384. doi: 10.1186/1471-2334-12-384.
23. Abd-El-Fattah AA, Sadik NA, Shaker OG, Aboulftouh ML (2013) Differential microRNAs expression in serum of patients with lung cancer, pulmonary tuberculosis, and pneumonia. Cell Biochem Biophys. 2013 Apr 5. [Epub ahead of print].
24. Kirschner MB, Kao SC, Edelman JJ, Armstrong NJ, Vallely MP, et al. (2011) Haemolysis during sample preparation alters microRNA content of plasma. PLoS One 6(9): e24145. doi: 10.1371/journal.pone.0024145.
25. R Development Core Team (2011) R: A language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austria, ISBN 3-900051-07-0. Available: http://www.R-project.org/. Accessed 2013 June 14.
26. Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19(2): 185-193.
27. Rao YL, Lee Y, Jarjoura D, Ruppert AS, Liu CG, et al. (2008) A comparison of normalization techniques for microRNA microarray data. Stat Appl Genet Mol Biol 7(1): Article22. doi: 10.2202/1544-6115.1287.
28. Deo A, Carlsson J, Lindlö f A (2011) How to choose a normalization strategy for miRNA quantitative real-time (qPCR) arrays. J Bioinform Comput Biol 9(6): 795-812.
29. Yohai VJ (1987) High Breakdown-Point and High Efficiency Robust Estimates for Regression. Ann Stat 15: 642-656.
30. Salibian-Barrera M, Yohai VJ (2008) High breakdown point robust regression with censored data. Ann Stat 36: 118-146.
31. Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, et al. (2009) Circos: An information aesthetic for comparative genomics. Genome Res 19: 1639-1645. doi: 10.1101/gr.092759.109.
32. Good PI (2005) Permutation, parametric, and bootstrap tests of hypotheses. Springer. 336 p.
33. Benjamini Y, Yekutieli D (2001) The control of the false discovery rate in multiple testing under dependency. Ann Stat 29: 1165-1188.
34. Zou KH, Hall WJ, Shapiro DE (1997) Smooth non-parametric receiver operating characteristic (ROC) curves for continuous diagnostic tests. Stat Med 16: 2143-2156.
35. Tipping ME (2001) Sparse Bayesian learning and the relevance vector machine. Journal Mach Learn Res 1: 211-244.
36. Lapedriza A, Segui S, Masip D, Vitria J (2008) A sparse Bayesian approach for joint feature selection and classifier learning. Pattern Anal Appl 11: 299-308.
37. Braun AC, Weidner U, Hinz S (2012) Classification in High-Dimensional Feature Spaces-Assessment Using SVM, IVM and RVM With Focus on Simulated EnMAP Data. IEEE Journal of Selected Topics in Applied Earth Observations and Remote Sensing 5: 436-443.
38. Agranoff D, Fernandez-Reyes D, Papadopoulos MC, Rojas SA, Herbster M, et al. (2006) Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 368(9540): 1012-1021.
39. Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, et al. (2007) Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Mol Med (Berl) 85(6): 613-621.
40. Mistry R, Cliff JM, Clayton CL, Beyers N, Mohamed YS, et al. (2007) Gene-expression patters in whole blood identify subjects at risk for recurrent tuberculosis. J Infect Dis 195(3): 357-365.
41. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, et al. (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466(7309): 973-977. doi: 10.1038/nature09247.
42. Maertzdorf J, Repsilber D, Parida SK, Stanley K, Roberts T, et al. (2011) Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun 12(1): 15-22. doi: 10.1038/gene.2010.51.
43. Lesho E, Forestiero FJ, Hirata MH, Hirata RD, Cecon L, et al. (2011) Transcriptional responses of host peripheral blood cells to tuberculosis infection. Tuberculosis (Edinb) 91(5): 390-399. doi: 10.1016/j.tube.2011.07.002.
44. Wang C, Yang S, Sun G, Tang X, Lu S, et al. (2011) Comparative miRNA expression profiles in individuals with latent and active tuberculosis. PLoS One 6(10): e25832. doi: 10.1371/journal.pone.0025832.
45. Liu Y, Wang X, Jiang J, Cao Z, Yang B, et al. (2011) Modulation of T cell cytokine production by miR-144* with elevated expression in patients with pulmonary tuberculosis. Mol Immunol 48(9-10): 1084-1090. doi: 10.1016/j.molimm.2011.02.001.
46. Yi Z, Fu Y, Ji R, Li R, Guan Z (2012) Altered microRNA signatures in sputum of patients with active pulmonary tuberculosis. PLoS One 7(8): e43184. doi:10.1371/journal.pone.0043184.
47. Olivier I, Loots du T (2012) A metabolomics approach to characterise and identify various Mycobacterium species. J Microbiol Methods 88(3): 419-426. doi: 10.1016/j.mimet.2012.01.012.
48. Ajit SK (2012) Circulating microRNAs as biomarkers, therapeutic targets, and signaling molecules. Sensors (Basel) 12(3): 3359-3369. doi: 10.3390/s120303359.
49. Schoof CR, Botelho EL, Izzotti A, Vasques Ldos R (2012) MicroRNAs in cancer treatment and prognosis. Am J Cancer Res 2(4): 414-433.